摘要
目的观察尤瑞克林联合丁苯酞治疗急性脑梗死的临床疗效。方法将急性脑梗死患者80例采用抽签法分为治疗组和对照组各40例,对照组给予抗血小板和脑保护等神经内科常规治疗,治疗组在对照组治疗的基础上给予尤瑞克联合丁苯酞治疗,比较2组治疗前后美国国立卫生研究院卒中量表(NIHSS)评分和临床疗效。结果治疗前2组NIHSS评分比较差异无统计学意义(P>0.05);治疗后2组NIHSS评分均有下降,且治疗组明显低于对照组,差异有统计学意义(P<0.05或P<0.01)。治疗组总有效率为87.50%明显高于对照组的70.00%,差异有统计学意义(P<0.01)。结论尤瑞克林联合丁苯酞治疗急性期脑梗死疗效显著,值得临床推广。
Objective To observe the clinical effect of eureklin combined with butylphthalide in acute cerebral infarction. Methods 80 cases patients with acute cerebral infarction were randomly divided into treatment group and control group,each of 40 cases. Control group was treated by anti-platelet and brain protection of neurology routine treatment. Treatment group was treated by yuruike combined with phthalide treatment,on the basis of control group. After treatment,compared the NIHSS score before and after treatment and clinical effect of 2 groups. Results The NIHSS score before treatment of 2 groups was no statistic significantly（ P〉0. 05）. The NIHSS score of 2 group after treatment were decreased,and the NIHSS score of treatment group was lower than that of control group,the difference was statistic significantly（ P〈0. 05 or P〈 0. 01）. The total effective rate of treatment group（ 87. 50%） was higher than that of control group（ 70. 00%）,the difference was statistic significantly（ P 0. 01）. Conclusion Eureklin combined with butylphthalide in acute cerebral infarction has an good effect,worthy of clinical application.
出处
《临床合理用药杂志》
2017年第7期12-13,共2页
Chinese Journal of Clinical Rational Drug Use
关键词
尤瑞克林
丁苯酞
急性
脑梗死
Erythromycin
Butylphthalide
Acute
cerebral infarction
